Targeting aberrant splicing in myelodysplastic syndromes: biologic rationale and clinical opportunity

Documenti analoghi

• Myelodysplastic Syndrome Associated with Acquired Beta Thalassemia: “BTMDS”
  di: Brunner, Andrew M., et al.
  Pubblicazione: (2016)
• Recent Advances in the Cellular and Molecular Understanding of Myelodysplastic Syndromes: Implications for New Therapeutic Approaches
  di: Brunner, Andrew M., et al.
  Pubblicazione: (2018)
• The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
  di: Yang, Yi-Tsung, et al.
  Pubblicazione: (2018)
• Myelodysplastic syndromes current treatment algorithm 2018
  di: Steensma, David P.
  Pubblicazione: (2018)
• New Strategies in Myelodysplastic Syndromes: Application of molecular diagnostics to clinical practice
  di: Tothova, Zuzana, et al.
  Pubblicazione: (2013)